1. Home
  2. Live Updates
  3. Janssen biotech inc

Live Breaking News & Updates on Janssen biotech inc

Stay informed with the latest breaking news from Janssen biotech inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Janssen biotech inc and stay connected to the pulse of your community

Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $6.29

Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $6.29
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Merck-kga , Merck-kgaa , Affinity-asset-advisors , Newtyn-management , Mersana-therapeutics-inc , Jpmorgan-chase-co , Mersana-therapeutics-company-profile , Janssen-biotech-inc , Nasdaq , Asana-biosciences

Johnson & Johnson receives positive CHMP opinion for

This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of...

Singapore , Belgium , Saclay , France-general- , France , Beerse , Region-flamande , United-states , American , Nicolas-girard , Henar-hevia , Institut-curie

Financial Contrast: Anixa Biosciences (NASDAQ:ANIX) vs. MacroGenics (NASDAQ:MGNX)

Financial Contrast: Anixa Biosciences (NASDAQ:ANIX) vs. MacroGenics (NASDAQ:MGNX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Rockville , Maryland , California , Anixa-biosciences , Anixa-bioscience , Anixa-biosciences-inc , Janssen-biotech-inc , Incyte-corporation , Zai-lab , Macrogenics-inc , Get-free-report

CURE Media Group and Oncology Nursing News® announce

Mooney was recognized for her remarkable contributions in oncology care...

Memorial-sloan-kettering-cancer-center , New-york , United-states , Dana-farber-cancer-institute , Massachusetts , Louisiana , New-orleans , Texas , Boston , Washington , America , Lr-bobby-goldsmith

BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design

SAN MATEO, Calif.--(BUSINESS WIRE)--Apr 24, 2024--

San-francisco , California , United-states , Bighat-biosciences , Mark-depristo , Elizabeth-schwarzbach , Twitter , Janssen-biotech-inc , Johnson , Hat-biosciences , Business-wire , Region

Celltrion Sees Market Share of Remsima Rising in European Nations

Celltrion Sees Market Share of Remsima Rising in European Nations
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Seoul , Soult-ukpyolsi , South-korea , United-kingdom , France , Spain , Germany , Italy , Britain , Celltrion-inc , Janssen-biotech-inc

Johnson & Johnson : CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy

Media contact:




Investor contact:




...

Spain , United-states , China , Belgium , Beerse , Region-flamande , Chinese , American , Edmond-chan , Jenni-mildon , Ciltacabtagene-autoleucel , European-commission-grants-conditional-approval

Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma

Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the significance of the FDA approval of cilta-cel in relapsed/refractory multiple myeloma.

New-york , United-states , Saadz-usmani , Johnson , Oncologic-drugs-advisory-committee , Janssen-biotech-inc , Meeting-of-the-oncologic-drugs-advisory-committee , Drugs-advisory-committee , Myeloma-service , Memorial-sloan-kettering-cancer-center ,

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma

New indication for this one-time infusion may provide patients with a treatment-free respite as early as first relapse

...

Japan , China , United-states , New-jersey , American , Ying-huang , Hemophagocytic-lymphohistiocytosis , Medicinal-devices-agency , Janssen-cilag-international , Johnson , Japan-ministry-of-health , Exchange-commission-on

Legend Biotech (LEGN) Reports CARVYKTI Approved in EU

Legend Biotech (LEGN) Reports CARVYKTI Approved in EU
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ying-huang , Legend-biotech-corporation , Janssen-biotech-inc , European-medicines-agency , Johnson , Janssen-cilag-international , European-commission , Drug-administration , Legend-biotech , Chief-executive-officer , Janssen-biotech ,